The US Food and Drug Administration on 4 February gave its stamp of approval under its Emergency Use Authorization (EUA) process to a 2019-novel coronavirus test that was developed and already in use by Centers for Disease Control and Prevention (CDC) laboratories.
The authorization permits any CDC-qualified state or local laboratory in the US to apply the RT-PCR diagnostic assay to newly...




